Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: A randomized, double-blind, parallel group clinical study

International Tinnitus Journal

Volumn 8, Issue 2, 2002, Pages 115-123

  Novotný, Miroslav ^a   Kostřica, Rom ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Betahistine; Cinnarizine and dimenhydrinate; M ni re's disease; Vertigo

Indexed keywords

ARLEVERT; BETAHISTINE DIMESILATE; CINNARIZINE; DIMENHYDRINATE;

ADULT; ARTICLE; CALORIC VESTIBULAR TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIOCORPOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTRONYSTAGMOGRAPHY; FEMALE; HEARING LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; NEUROSIS; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TINNITUS; UNTERBERGER TEST; VERTIGO;

ADULT; AGED; BETAHISTINE; CINNARIZINE; DIMENHYDRINATE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HISTAMINE AGONISTS; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MENIERE'S DISEASE; MIDDLE AGED; TREATMENT OUTCOME; VERTIGO;

EID: 0036913871     PISSN: 09465448     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kitahara M. Concepts and Diagnostic Criteria of Ménière's Disease. In M. Kitahara (ed), Ménière's Disease. Berlin: Springer-Verlag, 1990:3-12.
2. Michel O. Morbus Ménière und Verwandte Gleichgewichtsstörungen. Stuttgart: Thieme, 1998.
3. Dickens J, Graham SS. Ménière's disease - 1983-1989. Am J Otol 11:51-65, 1990.
4. Bjorab DI, Bhansali SA, Battista RA. Peripheral Vestibular Disorders. In RK Jackler, DE Brackmann (eds), Neurotology. St. Louis: Mosby-Year Book, 1994:629-650.
5. Wackym PA, Blackwell KE, Nyerges AM. Pharmacotherapy of Vestibular Dysfunction. In RK Jackler, DE Brackmann (eds), Neurotology. St. Louis: Mosby-Year Book, 1994:543-553.
6. Waldfahrer F, Finke C, Iro H. Aktuelle aspekte der medikamentösen schwindeltherapie. In W Stoll (ed), Vestibuläre Erkrankungen. Stuttgart: Thieme, 2001:98-107.
7. Godlowski Z. Pathogenesis and management of Ménière's syndrome in terms of microcirculation. Angiology 16:644, 1965.
8. Michel O. Morbus Ménière. Stuttgart: Thieme, 1988.
9. Novotný M. Menierova Choroba. Praha: Avicenum, 1991:171.
10. Schremmer D, Bognar-Steinberg I, Baumann W, Pytel J. Efficacy and tolerability of a fixed combination of cinnarizine and dimenhydrinate in treatment of vertigo. Analysis of data from five randomised, double-blind clinical studies. Clin Drug Invest 18:355-368, 1999.
11. Novotný M, Kostřica R, Círek Z. The efficacy of Arlevert therapy for vertigo and tinnitus. Int Tinnitus J 5:60-62, 1999.
12. Kessler L. Treatment of vertigo with a combination of cinnarizine and dimenhydrinate. Eur Arch Otorhinolaryngol 255:80, 1998.
13. Emanuel MB. Specific calcium antagonists in the treatment of peripheral vascular disease. Angiology 30:454-469, 1979.
14. Godfraind T, Towse G, van Nueten JM. Cinnarizine - A selective calcium entry blocker. Drugs Today 18:27-42, 1982,
15. Nilles R. Direkter nachweis einer protektiven wirkung von kalziumantagonisten im innenohr. HNO 43:716-723, 1995.
16. Ben-David J, Podoshin L, Fradis M. A comparative craniocorpography study on the findings in the Romberg standing test versus the Unterberger/Fukuda stepping test in vertigo patients. Acta Otorhinolaryngol Belg 39:924-932, 1985.
17. Claussen C-F. Der Schwindel-kranke Patient. Grundlagen der Neurootologie und Äquilibriometrie. Hamburg: Dr. Werner Rudat, 1992.
18. Hahn A, Schneider D, Claussen C-F. Neurootologic findings in the patients with so-called Ménière-like disease. Neurotol Newslett 5:88-94, 2000.
19. Jongkees LBW. Which is the preferable method of performing the caloric test? Acta Otolaryngol 49:594, 1949.
20. Glasscock ME III, Cueva R, Thedinger BA. Handbook of Vertigo. New York: Raven Press, 1990.
21. Pfaltz CR, Matéfi L. Ménière's disease - Or syndrome? A critical review of diagnosis criteria. In K-H. Vosteen, H. Schuknecht, CR Pfalz, et al. (eds), Ménière's Disease. Pathogenesis, Diagnosis and Treatment. Stuttgart: Thieme Verlag and Thieme-Stratton, 1981:1-10.
22. Hahn A. Audiovestibular findings in the course of Ménière's disease. In O Sterkers, E Ferrary, R Dauman, et al. (eds), Ménière's Disease 1999 - Update. Proceedings of the Fourth International Symposium on Ménière's Disease, Paris. The Hague: Kugler Publications, 2000: 285-289.
23. Katsarkas A. Hearing loss and vestibular dysfunction in Ménière's disease. Acta Otolaryngol 116:185-188, 1996.
24. Kveton JF. Symptoms of vestibular disease. In RK Jackler, DE Brackmann, (eds), Neurotology. St. Louis: Mosby-Year Book, 1994:145-151.
25. Mizukoshi K, Aso S, Watanabe Y. Prediction of Prognosis for Hearing in Ménière's Disease. In M Kitahara (ed), Ménière's Disease. Berlin: Springer, 1990:121-124.
26. Laurikainen E, Miller JM, Nuttall AL, Quirk WS. The vascular mechanism of action of betahistine in the inner ear of the guinea pig. Eur Arch Otorhinolaryngol 225: 119-123, 1998.
27. 3-receptors and pharmacology of betahistine. Acta Otolaryngol Suppl 526:43-46, 1997.
28. Oosterveld WJ. Cinnarizine in the Vertiginous syndrome. In G Towse (ed), Cinnarizine and the Vertiginous Syndrome. International Congress and Symposium Series No.33. London: Royal Society of Medicine and Academic Press, 1979:29-37.
29. Jaju BP, Wang SC. Effects of diphenhydramine and dimenhydrinate on vestibular neuronal activity of cat: A search for the locus of their antimotion sickness action. J Pharmacol Exp Ther 176:718-724, 1971.
30. Kukwa L. Selektive pharmakotherapeutische Stammhirndämpjung, 2nd Ed. Hamburg: Neu-Isenburg: Dr. Werner Rudat, 1981:9-14.
31. Stoll W. Otogener schwindel. Differenzierung und therapie. Laryngorhinootol 72:311-315, 1993.